Company Profile

Hope Pharmaceuticals
Profile last edited on: 8/17/2015      CAGE: 02UA6      UEI: JZJEZA63JTD8

Business Identifier: Antidote for acute cyanide poisoning and other pharamaceuticals
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

16416 North 92nd Street Suite 125
Scottsdale, AZ 85260
   (800) 755-9595
Location: Single
Congr. District: 01
County: Maricopa

Public Profile

Hope Pharmaceuticals offers various pharamaceuticals. In August 2011, Hope Pharmaceuticals announced launch of Nithiodote©, a new antidote for the treatment of acute cyanide poisoning. This drug was patented two years later. The firm also produce (1) Scopace: to help prevent motion sickness, providing comfort to those prone to nausea from rough seas, turbulent flights, and bumpy drives. (2) Aminobenzoate Potassium to treat and prevent the development and progression of penile curvature associated with Peyronie's Disease. (3) Versiclear Lotion is indicated to treat Tinea Versicolor, which is a fungal infection of the skin that causes pigment loss. This product combines antifungal medicine plus skin penetrating agents for double action treatment. (4) Sal-TropineSal-Tropine indicated to help reduce excessive salivation and control drooling. DENTISTS: maintain a dry field during dental procedures with Sal-Tropine. (5) Acid Jelly indicated to treat long term vaginal inflammation which may be caused by infection with micro-organisms.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Hope Sherman -- President

  Craig W Sherman